The FDA states that GLP-1 medications for weight management should only be used in conjunction with behavior modification, and now the WeightWatchers GLP-1 Program will be that complementary tool to provide the necessary behavioral support
About 22 million adults in the United States have MASH, with cases expected to rise to 27 million by 2030
[00:28:40] Emily Field: Because if we just want this whole episode talking about why muscle matters, why training matters, and why preserving strength matters, then we also have to acknowledge this
Most patients start on a low dose that is gradually increased over several months
GLP-1 Treatments, Semaglutide or Tirzepatide causes food cravings to dissipate, which in turn helps you avoid bad foods and snacks with no nutritional value
January 2026: Now that an MDL has been created for those who have experienced vision loss after taking Mounjaro and other GLP-1 drugs, the court will be taking several steps to advance the litigation